Atypical Chronic Myeloid Leukemia: Where Are We Now?

Atypical Chronic Myeloid Leukemia: Where Are We Now?

Atypical chronic myeloid leukemia, <i>BCR-ABL1</i> negative (aCML) is a rare myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) with a high rate of transformation to acute myeloid leukemia, and poor survival. Until now, the diagnosis has been based on morphological grounds...

Full description

Bibliographic Details
Main Authors: Elena Crisà, Maura Nicolosi, Valentina Ferri, Chiara Favini, Gianluca Gaidano, Andrea Patriarca
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
Atypical CML
next generation sequencing
target therapy
Online Access:https://www.mdpi.com/1422-0067/21/18/6862

Internet

https://www.mdpi.com/1422-0067/21/18/6862

Similar Items